Report cover image

Water And Wastewater Treatment Equipment Market Size, Share & Trends Analysis Report By Application (Municipal, Industrial), By Process By Equipment (Primary Treatment, Tertiary Treatment, Tertiary Treatment), By Region, And Segment Forecasts, 2026 - 2033

Publisher Grand View Research
Published Dec 18, 2025
Length 90 Pages
SKU # GV20723860

Description

Water And Wastewater Treatment Equipment Market Summary

The global water and wastewater treatment equipment market size was estimated at USD 71.01 billion in 2025 and is projected to reach USD 106.39 billion by 2033, growing at a CAGR of 5.3% from 2026 to 2033. The market growth is driven by factors such as population growth, urbanization, industrialization, and stricter environmental regulations.

Rising awareness of environmental pollution, stringent management regulations, and a growing demand for sustainable and efficient wastewater treatment solutions are expected to contribute to the expansion of the industry. The market is further set to grow due to increasing industrialization, population growth, and stricter government regulations on wastewater discharge. Companies in the water and wastewater treatment equipment industry are forming partnerships with end-users to promote the adoption of new technologies. Increased investment in research and development to improve technology efficiency is also expected to drive market growth. Small and medium-sized businesses are adopting new water and wastewater treatment technologies, creating opportunities for growth.

Many opportunities have become prevalent in the industry due to technological advancements and the introduction of innovative treatment solutions, providing huge potential for market players to implement such solutions to gain a competitive advantage. The market is witnessing growth in the adoption of membrane filtration and ultraviolet disinfection technologies because of their high efficacy in treating water and wastewater.

Global Water And Wastewater Treatment Equipment Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the water and wastewater treatment equipment market report on the basis of application, process by equipment, and region:
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Municipal
  • Industrial
  • Process by Equipment Outlook (Revenue, USD Billion, 2021 - 2033)
  • Primary treatment
  • Primary Clarifier
  • Sludge Removal
  • Grit Removal
  • Pre-Treatment
  • Others
  • Secondary treatment
  • Activated Sludge
  • Sludge Treatment
  • Others
  • Tertiary treatment
  • Tertiary Clarifier
  • Filters
  • Chlorination Systems
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Norway
  • Finland
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Central & South America
  • Brazil
  • Argentina
  • Venezuela
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

90 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Services
1.2.2. Biospecimen Type
1.2.3. Biobank Type
1.2.4. Application
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biobanks Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increased focus on precision medicine and genetic testing
3.2.1.2. Changes in biobanking operations
3.2.1.3. Increase in the number of clinical trials globally
3.2.1.4. Growing industry and research collaborations
3.2.1.5. Technology advancement and automation
3.2.2. Market restraint analysis
3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
3.2.2.2. Sustainability challenges for biobanks
3.2.2.3. Other challenges in biobanking specimens for research
3.3. Biobanks Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Biobanks Market: Product & Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Product & Services Market Share, 2025 & 2033
4.3. Product
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
4.4.1. Biobanking Equipment
4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2. Temperature Control Systems
4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.2. Freezers & Refrigerators
4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.3. Cryogenic Storage Systems
4.4.1.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.5. Thawing Equipment
4.4.1.2.6. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3. Incubators & Centrifuges
4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.4. Alarms & Monitoring Systems
4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.5. Accessories & Other Equipment
4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Biobanking Consumables
4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. Laboratory Information Management Systems
4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
4.6. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.6.1. Biobanking & repository
4.6.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.2. Lab processing
4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.3. Qualification/ Validation
4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.4. Cold Chain Logistics
4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.5. Other Services
4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Biobanks Market: Biospecimen Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biospecimen Type Market Share, 2025 & 2033
5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
5.3.1. Human Tissues
5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.2. Human Organs
5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3. Stem Cells
5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.2. Adult Stem Cells
5.3.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.3. Embryonic Stem Cells
5.3.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.4. IPS Cells
5.3.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.5. Other Stem Cells
5.3.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.4. Other biospecimens
5.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Biobanks Market: Biobank Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Biobank Type Market Share, 2025 & 2033
6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
6.3.1. Physical/Real biobanks
6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.2. Tissue Biobanks
6.3.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.3. Population-based biobanks
6.3.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.4. Genetic (DNA/RNA)
6.3.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.5. Disease-Based biobanks
6.3.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.2. Virtual biobanks
6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Biobanks Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Application Market Share, 2025 & 2033
7.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
7.3.1. Therapeutics
7.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.2. Drug discovery & clinical research
7.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.3. Clinical Diagnostics
7.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.4. Other Applications
7.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Biobanks Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2025 & 2033
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Qiagen
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Hamilton Company
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Tecan Trading AG
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Danaher Corporation
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Becton, Dickinson, and Company (BD)
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Biocision, LLC.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Taylor-Wharton
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Charles River Laboratories
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Lonza
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Stemcell Technologies
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. Biovault Family
9.4.13.1. Company overview
9.4.13.2. Financial performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. Promocell Gmbh
9.4.14.1. Company overview
9.4.14.2. Financial performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives
9.4.15. Precision Cellular Storage Ltd. (Virgin Health Bank)
9.4.15.1. Company overview
9.4.15.2. Financial performance
9.4.15.3. Product benchmarking
9.4.15.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us